Results for tag: "Memory Impairment Drug"

The Memory Impairment Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Memory Impairment Drugs are used to treat memory loss, dementia, and other cognitive impairments. These drugs are typically prescribed to elderly patients, although they may also be used to treat younger patients with memory-related conditions. Memory Impairment Drugs are typically divided into two categories: cholinesterase inhibitors and NMDA receptor antagonists. Cholinesterase inhibitors are used to treat mild to moderate memory loss, while NMDA receptor antagonists are used to treat more severe memory impairments. Some companies in the Memory Impairment Drug market include Pfizer, Novartis, Merck, and Johnson & Johnson. Show Less Read more